Mayflower Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.68M Buy
3,906
+129
+3% +$132K 0.4% 68
2026
Q1
$3.47M Buy
3,777
+12
+0.3% +$12.2K 0.42% 66
2025
Q4
$4.05M Sell
3,765
-1
-0% -$956 0.49% 55
2025
Q3
$2.87M Buy
3,766
+438
+13% +$326K 0.36% 70
2025
Q2
$2.59M Buy
3,328
+155
+5% +$120K 0.36% 68
2025
Q1
$2.62M Sell
3,173
-4
-0.1% -$3.33K 0.4% 61
2024
Q4
$2.45M Buy
3,177
+42
+1% +$34.8K 0.37% 67
2024
Q3
$2.78M Buy
3,135
+37
+1% +$33.3K 0.42% 59
2024
Q2
$2.81M Buy
3,098
+66
+2% +$52.8K 0.46% 54
2024
Q1
$2.36M Sell
3,032
-107
-3% -$76.1K 0.39% 63
2023
Q4
$1.83M Buy
3,139
+62
+2% +$36.2K 0.25% 83
2023
Q3
$1.65M Sell
3,077
-7,506
-71% -$3.87M 0.25% 84
2023
Q2
$4.96M Buy
10,583
+6
+0.1% +$2.52K 0.64% 37
2023
Q1
$3.63M Sell
10,577
-710
-6% -$239K 0.48% 49
2022
Q4
$4.13M Buy
11,287
+12
+0.1% +$4.25K 0.57% 38
2022
Q3
$3.65M Buy
11,275
+7,387
+190% +$2.34M 0.59% 39
2022
Q2
$1.26M Sell
3,888
-24
-0.6% -$7.2K 0.19% 96
2022
Q1
$1.12M Buy
3,912
+107
+3% +$27.5K 0.15% 104
2021
Q4
$1.05M Buy
3,805
+21
+0.6% +$5.32K 0.14% 104
2021
Q3
$917K Buy
3,784
+35
+0.9% +$8.64K 0.12% 116
2021
Q2
$861K Sell
3,749
-130
-3% -$26.1K 0.12% 118
2021
Q1
$725K Buy
3,879
+37
+1% +$7.24K 0.11% 126
2020
Q4
$649K Buy
+3,842
New +$574K 0.11% 132

Other funds holding LLY

Mayflower Financial Advisors's LLY Position: Q2 2026 in Review

Mayflower Financial Advisors increased its Eli Lilly (LLY) stake by 3.4% in Q2 2026, buying an estimated $132K and bringing the position to 3,906 shares worth $4.68M. The position accounts for 0.4% of the portfolio, ranked #68.

Mayflower Financial Advisors first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.96M in Q2 2023. 1,763 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mayflower Financial Advisors held 3,906 shares of Eli Lilly worth $4.68M as of Q2 2026.
  • Mayflower Financial Advisors bought 129 Eli Lilly shares in Q2 2026, an estimated $132K.
  • Eli Lilly made up 0.4% of Mayflower Financial Advisors's portfolio in Q2 2026, its #68 holding.
  • Mayflower Financial Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Mayflower Financial Advisors's Eli Lilly position peaked at $4.96M in Q2 2023.
  • 1,763 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mayflower Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.